📷 Image: Wikimedia Commons / National Institutes of Health (NIH)
Business
BioNTech, Novavax, Moderna Shares Rise on NIH Cancer Vaccine Report
✍️ Asianet Newsable
🗓 10 Oct 2026, 10:38 AM
👁 17
Shares of BioNTech, Novavax and Moderna led a rally in vaccine stocks after a report indicated the National Institutes of Health is pushing forward with cancer vaccine development.
A news report that the National Institutes of Health is accelerating work on a cancer vaccine sparked investor interest in vaccine makers.
Shares of BioNTech, Novavax and Moderna responded strongly, leading the gains among vaccine-related stocks.
Market analysts said the NIH initiative could open new demand for preventive vaccines, although specifics of the program remain limited.
Shares of BioNTech, Novavax and Moderna responded strongly, leading the gains among vaccine-related stocks.
Market analysts said the NIH initiative could open new demand for preventive vaccines, although specifics of the program remain limited.